HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sundram, F Articles by Pavord, S Search for Related Content PubMed PubMed Citation Articles by Sundram, F Articles by Pavord, S

Thrombotic thrombocytopenic purpura associated with statin treatment

Department of Haematology, Leicester Royal Infirmary, Leicester, UK

Correspondence to:
Correspondence to:
Dr S Pavord
Department of Haematology, Leicester Royal Infirmary, Infirmary Square, Leicester LE1 5WW, UK; sp59{at}le.ac.uk

Thrombotic thrombocytopenic purpura (TTP) is a rare condition but associated with 90% mortality if left untreated. The diagnosis is usually made when there is thrombocytopenia and microangiopathic haemolytic anaemia, although the full pentad also includes fever, renal impairment, and neurological dysfunction. A variety of underlying causes have been implicated in acquired TTP including bacterial and viral infections, bone marrow and organ transplantation, pregnancy, immune disorders, and certain drugs. To date there is just one case report of TTP associated with statin treatment. The clinical course of a patient who presented with TTP after being started on simvastatin, a HMG-CoA inhibitor, is described.

Keywords: thrombotic thrombocytopenic purpura; simvastatin; statins

This article has been cited by other articles:

				P. Pattis and C. J Wiedermann Ezetimibe-Associated Immune Thrombocytopenia Ann. Pharmacother., March 1, 2008; 42(3): 430 - 433. [Abstract] [Full Text] [PDF]